Archibiome tattoo for resistant, responsive, and resilient cities
The REMEDY project aims to revolutionize architecture with engineered living materials that enhance building resilience and aesthetics through custom microbial inks, promoting a probiotic approach to design.
Projectdetails
Introduction
The REMEDY project proposes a game-changing technology in the form of an archibiome tattoo that will allow bespoke and high-resolution decoration and functionalisation of new and existing buildings. Our ambition is to achieve a breakthrough in fundamental research in microbiology and synthetic biology, transfer the know-how to materials science in the form of engineered living materials, and develop compatible biofabrication processes that allow personalised design in the architectural context.
Customisation of Building Appearance
We propose the customisation of building appearance with living and active interkingdom microbial inks that will act similarly to probiotic skincare products, enhancing biotherapeutic architecture. The tailored and engineered microbial consortia will create a beneficial microbiome, providing:
- Resilience and resistance against pathogenic microorganisms
- Carbon sequestration
- Oxygen production
- Bioremediation
among others.
Evaluation and Analysis
We will use the latest metagenomic tools to evaluate the functionome of the created microbial consortia along every step in the development of living inks. In silico analysis will be applied to predict combinations of microorganisms based on genome-scale models of metabolism.
Machine Learning Implementation
Machine learning models will be implemented for predictive analysis of growth patterns and structural outcomes, providing insights for further optimising ink formulations and printing parameters.
Impact on the Building Industry
REMEDY will introduce metabolic thinking in the circular building industry, boost probiotic architecture, and initiate a microbial revolution that aims to change the negative perception of microorganisms in architecture. The “high-risk” idea proposed by the interdisciplinary consortium will deliver a “high-gain” solution in the form of probiotic architecture.
A New Dimension in Materials
REMEDY will provide a new dimension that has not yet existed for conventional materials – life. It will change the way we perceive, experience, understand, design, use, and transform materials.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.998.122 |
Totale projectbegroting | € 2.998.122 |
Tijdlijn
Startdatum | 1-2-2025 |
Einddatum | 31-1-2029 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- INNORENEW COE CENTER ODLICNOSTI ZA RAZISKAVE IN INOVACIJE NA PODROCJU OBNOVLJIVIH MATERIALOV IN ZDRAVEGA BIVANJSKEGA OKOLJApenvoerder
- UNIVERZA V LJUBLJANI
- TECHNISCHE UNIVERSITAET GRAZ
- TIGER Coatings
- XYLOTRADE B.V.
- QRES TECHNOLOGIES SRO
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Bacteria Biofilm as bio-factory for tissue regenerationBIOACTION aims to transform biofilm-associated infections into a resource for tissue regeneration using functionalized bio-hydrogels and engineered liposomes, enhancing implant technology and health outcomes. | EIC Pathfinder | € 2.903.862 | 2023 | Details |
SKIN MICROBIAL DEVICESSKINDEV aims to develop Smart Skin Microbial Devices for non-invasive monitoring and treatment of atopic dermatitis through innovative sensing technologies and genetic engineering. | EIC Pathfinder | € 1.718.408 | 2023 | Details |
PRInted Symbiotic Materials as a dynamic platform for Living Tissues productionPRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications. | EIC Pathfinder | € 2.805.403 | 2022 | Details |
Digital design and robotic fabrication of biofoams for adaptive mono-material architectureThe ARCHIBIOFOAM project aims to develop multifunctional, 3D-printable biofoams with programmable properties for sustainable architecture, enhancing performance while reducing CO2 emissions. | EIC Pathfinder | € 3.422.982 | 2024 | Details |
On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic DrugsDevelop a bioresorbable chemical sensing system for real-time monitoring of doxorubicin in-vivo, enhancing personalized cancer treatment while eliminating the need for device retrieval surgery. | EIC Pathfinder | € 2.606.250 | 2022 | Details |
Bacteria Biofilm as bio-factory for tissue regeneration
BIOACTION aims to transform biofilm-associated infections into a resource for tissue regeneration using functionalized bio-hydrogels and engineered liposomes, enhancing implant technology and health outcomes.
SKIN MICROBIAL DEVICES
SKINDEV aims to develop Smart Skin Microbial Devices for non-invasive monitoring and treatment of atopic dermatitis through innovative sensing technologies and genetic engineering.
PRInted Symbiotic Materials as a dynamic platform for Living Tissues production
PRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications.
Digital design and robotic fabrication of biofoams for adaptive mono-material architecture
The ARCHIBIOFOAM project aims to develop multifunctional, 3D-printable biofoams with programmable properties for sustainable architecture, enhancing performance while reducing CO2 emissions.
On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic Drugs
Develop a bioresorbable chemical sensing system for real-time monitoring of doxorubicin in-vivo, enhancing personalized cancer treatment while eliminating the need for device retrieval surgery.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Bioinspired living skin for architectureThe ARCHI-SKIN project aims to develop a bioactive protective coating using fungal biofilms to enhance the durability and functionality of various materials through innovative design and in-situ methods. | ERC Consolid... | € 1.999.000 | 2022 | Details |
Microbiome-based diagnostics and therapeuticsThis project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression. | ERC Proof of... | € 150.000 | 2023 | Details |
Additive Manufacturing of Living Composite MaterialsThis project aims to create living composites by integrating biological systems into engineering materials, enhancing adaptability, healing, and performance through innovative fabrication techniques. | ERC Consolid... | € 1.999.491 | 2023 | Details |
InnomABsIPA onderzoekt de haalbaarheid van het ontwikkelen van menselijke eiwitten als alternatief voor antibiotica tegen antimicrobiële resistentie. | Mkb-innovati... | € 14.888 | 2023 | Details |
Revolutionizing Skin Health with our Advanced Engineered BiotherapeuticsThe SkinEngineering project aims to advance a patented biotherapeutic technology using genetically engineered skin bacteria for effective acne treatment, targeting regulatory validation and commercialization. | EIC Transition | € 2.499.999 | 2025 | Details |
Bioinspired living skin for architecture
The ARCHI-SKIN project aims to develop a bioactive protective coating using fungal biofilms to enhance the durability and functionality of various materials through innovative design and in-situ methods.
Microbiome-based diagnostics and therapeutics
This project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression.
Additive Manufacturing of Living Composite Materials
This project aims to create living composites by integrating biological systems into engineering materials, enhancing adaptability, healing, and performance through innovative fabrication techniques.
InnomABs
IPA onderzoekt de haalbaarheid van het ontwikkelen van menselijke eiwitten als alternatief voor antibiotica tegen antimicrobiële resistentie.
Revolutionizing Skin Health with our Advanced Engineered Biotherapeutics
The SkinEngineering project aims to advance a patented biotherapeutic technology using genetically engineered skin bacteria for effective acne treatment, targeting regulatory validation and commercialization.